Nantahala Capital Management’s Filana Therapeutics FLNA Stock Holding History

Nantahala Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-647,053	Closed	-$654K	–	104
2018 Q3	$654K	Hold	647,053	–	–	0.02%	95
2018 Q2	$1.33M	Hold	647,053	–	–	0.05%	86
2018 Q1	$4.59M	Buy	647,053 +300,000	+86%	+$2.02M	0.21%	62
2017 Q4	$1.39M	Hold	347,053	–	–	0.06%	72
2017 Q3	$1.41M	Buy	347,053 +3	+0%	+$11	0.07%	62
2017 Q2	$1.44M	Hold	347,050	–	–	0.11%	58
2017 Q1	$2.17M	Sell	347,050 -142,858	-29%	-$648K	0.24%	47
2016 Q4	$1.96M	Sell	489,908 -63,068	-11%	-$292K	0.2%	50
2016 Q3	$3.87M	Sell	552,976 -266,356	-33%	-$4.41M	0.47%	42
2016 Q2	$12.6M	Sell	819,332 -99,882	-11%	-$1.58M	1.36%	22
2016 Q1	$14.3M	Buy	919,214 +88,992	+11%	+$1.15M	1.48%	18
2015 Q4	$10.2M	Buy	830,222 +181,978	+28%	+$2.41M	1.33%	21
2015 Q3	$8.3M	Buy	648,244 +3,158	+0.5%	+$39.9K	1.13%	28
2015 Q2	$7.81M	Buy	645,086 +331,893	+106%	+$4.55M	1.15%	29
2015 Q1	$4.14M	Buy	313,193 +64,987	+26%	+$877K	0.69%	45
2014 Q4	$3.53M	Buy	+248,206	New	+$4.3M	0.5%	57

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nantahala Capital Management's FLNA Position: Q4 2018 in Review

Nantahala Capital Management sold out of Filana Therapeutics (FLNA) in Q4 2018, closing a stake of 647,053 shares — an estimated $654K sold.

Nantahala Capital Management first reported a position in FLNA in Q4 2014 and held it in 16 quarters. The position peaked at $14.3M in Q1 2016. 25 funds tracked by Wall St. Rank hold FLNA as of Q4 2018.

Nantahala Capital Management reported no remaining Filana Therapeutics position as of Q4 2018 after selling out during the quarter.
Nantahala Capital Management sold 647,053 Filana Therapeutics shares in Q4 2018, an estimated $654K.
Nantahala Capital Management first reported a position in Filana Therapeutics in Q4 2014 and held it in 16 quarters.
Nantahala Capital Management's Filana Therapeutics position peaked at $14.3M in Q1 2016.
25 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2018.

Based on Nantahala Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.